Table 2 Clinical outcomes of study patients
| Â | Early Recovery | Late/Non-Recovery | p-value |
|---|---|---|---|
Number | 67 | 25 | Â |
Maximum creatinine level, mg/dl (mean ± SD) | 2.0 ± 0.9 | 3.6 ± 2.0 | < 0.0001 |
Minimal eGFR, ml/min (mean ± SD) | 45 ± 25 | 21 ± 9 | < 0.0001 |
RIFLE class, R/I/F | 42/18/7 | 0/6/19 | < 0.0001 |
Duration of AKI, days (mean ± SD) | 3.0 ± 1.8 | 21.5 ± 19.8 | < 0.0001 |
Patients on RRT, n (%) | 2 (3) | 15 (63) | < 0.0001 |
Patients with RBC transfusions, n (%) | 30 (45) | 19 (76) | 0.01 |
Red blood cell transfusions, n (mean ± SD) | 1.4 ± 2.3 | 3.7 ± 4.1 | < 0.001 |
Length of hospital stay, days (mean ± SD) | 34 ± 33 | 50 ± 31 | < 0.005 |
Length of ICU stay, days (mean ± SD) | 18 ± 20 | 31 ± 26 | < 0.01 |
28-day mortality, n (%) | 13 (20) | 11 (46) | < 0.05 |
90-day mortality, n (%) | 25 (34) | 15 (63) | NS |